-
Medherant Announces Appointment of New Chair
Medherant Ltd., a University of Warwick spin-out developing a novel transdermal drug delivery patch technology, is pleased to announce the appointment of Dr Ken Cunningham as Chair. Dr Cunningham joins Medherant as the company prepares to move into clinical studies with its leading TEPI Patch® technology.
-
CancerGene Connect Taps Seasoned Executive John Oberg as Vice President of Sales and Marketing
Dallas, USA, 29th January 2017 / Sciad Newswire / CancerGene Connect, a wholly owned Subsidiary of OMMDOM, Inc., a software development, commercialization, and technology sales company whose core competency is healthcare software, has announced the appointment of John Oberg as their inaugural Vice President of Sales and Marketing. Oberg will assume his new role effective on Monday, February 6th. In…
-
Cypralis granted new Innovate UK early stage award to develop cyclophilin D inhibitors targeting degenerative diseases
Cambridge, UK, 23rd January 2017 / Sciad Newswire / Cypralis, a life sciences company focused on the discovery of therapeutics for the modulation of peptidyl-prolyl isomerases (PPIases), has successfully completed its Innovate UK feasibility award and has been awarded new funding by Innovate UK, the UK’s innovation agency, under its BioMedical Catalyst competition. The feasibility study completed…
-
What to expect at Biotech and Money London 2017
This February Biotech and Money returns to London for its 3rd annual conference. From 7-8th February 400+ delegates, 100+ speakers and 150+ investors will come together for this two-day conference and partnering event, providing the education, strategies, solutions and contacts that life science companies need to enable more effective funding, investment, business planning and partnering within their businesses. …
-
Biotech and Money London adds Medtech and Money Day
London, UK, 18th January 2017 / Sciad Newswire / Biotech and Money London 2017, a C-level executive conference that helps build linkages and business opportunities for UK and European life science companies taking place on 7-8 February 2017, has added a Medtech and Money Day to help medtech executives, investors and pharma access high-value collaboration opportunities. Due…
-
ECI Partners Private Equity Investment in SAP Consultancy Edenhouse Solutions
Birmingham, UK, 13th January 2017 / Sciad Newswire / Edenhouse Solutions, a Birmingham based SAP consultancy, has today announced a funding investment by ECI Partners private equity firm. The current board will retain a controlling interest and will be joined by Richard Chapman from ECI and Chairman Simon Downing from the Civica Group. Founded in 2008, Edenhouse has…
-
Will Plant and Algae-Based Protein Consumption Overtake Animal-Based Foods?
San Francisco, UK, 12th January 2017 / Sciad Newswire / With the world’s population projected to hit 9.9 billion by 2050, experts are continuing to look for sustainable food sources to feed the masses. Over the past two years, the food-tech industry has seen a huge movement in alternative protein development. The big question is, will we ever…
-
The Future of Food
The start of a new year provides the opportunity to look at the upcoming events of 2017, and to get excited about what this year has to offer. One such event is the Future Food-Tech Summit taking place in San Francisco, March 29th – 30th 2017, as part of Rethink Ag and Food Innovation Week. Food shortage…
-
Synpromics announces a research collaboration with GE Healthcare to Extend the Toolbox for Production of Biologics
Edinburgh, UK, 4th January 2017 / Sciad Newswire / Synpromics Ltd, the leading synthetic promoter and gene control company, is pleased to announce a research collaboration with GE Healthcare to jointly develop customised synthetic promoters optimised for GE Healthcare’s proprietary biopharmaceutical manufacturing platform. Synpromics will develop a complex bar-coded library of synthetic promoters, using its proprietary PromPT™ platform,…
-
Prokarium and Probiomed in UK-Mexico Collaboration to Scale-Up Manufacture of Thermostable Vaccines with a Focus on Diarrhoea
Keele, UK and Mexico City, MX, 4th January 2017 / Sciad Newswire / Prokarium and Probiomed today announced the start of their collaboration to scale-up the manufacture of orally administered vaccines in a formulation that would enable stability at 40°C for several weeks. The first vaccine to be manufactured will be developed to prevent so-called ‘Montezuma’s revenge’ or…